Esperion Therapeutics, Inc. (ESPR)
3.91
+0.18
(+4.83%)
USD |
NASDAQ |
Dec 08, 16:00
3.92
+0.01
(+0.26%)
After-Hours: 20:00
Esperion Therapeutics Shareholders Equity (Quarterly): -451.36M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| Ovid Therapeutics, Inc. | 44.70M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.02M |
| Debt to Equity Ratio | -1.324 |
| Current Ratio | 1.147 |
| Net Debt Paydown Yield | -1.51% |